Although EXT1’s function in HCC is not clear, it has been reported as one of three Interferon-alpha (IFN-α)/5-fluorouracil (5-FU) therapy sensitizing genes in HCC [24]. The gene discussed is EXT1; the disease is hepatocellular carcinoma.